- AU$18.00m
- AU$14.64m
- AU$0.01m
Australia Stock Exchange release from PATRYS : Patrys proof of concept ADC significantly increases survival
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:05:59
Australia Stock Exchange release from PATRYS : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from PATRYS : Company Overview Presentation - September 2021
Australia Stock Exchange release from PATRYS : Patrys to Present at Lifesciences Webinar
Australia's Patrys jumps on progress in anti-cancer drug
Australia Stock Exchange release from PATRYS : PAT-DX3 proof of concept as potential ADC targeting antibody
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:20:35
Australia Stock Exchange release from PATRYS : Change of Director's Interest Notice
Australia Stock Exchange release from PATRYS : Application for quotation of securities - PAB
Australia Stock Exchange release from PATRYS : Section 708A Cleansing Statement
Australia Stock Exchange release from PATRYS : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 17:39:00
Australia Stock Exchange release from PATRYS : Appendix 4E and 2021 Annual Report
Australia's Patrys tumbles on manufacturing delays of cancer treatment
Brief: Patrys Expects Delay In Getting Components For Fermentation Media To Make PAT-DX1
Australia Stock Exchange release from PATRYS : Full size deoxymab PAT-DX3 crosses the blood brain barrier
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:33:26
Australia Stock Exchange release from PATRYS : Application for quotation of securities - PAB